• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

原发性神经内分泌前列腺癌伴肾上腺转移。

Primary neuroendocrine prostate cancer with adrenal gland metastasis.

作者信息

Muñoz López Antonio Yaromin, Domínguez Castillo Ricardo Emanuel, Rodenas Gil Erick Alejandro, Navarro Ruesga Iñigo, Morales Montor Jorge Gustavo, Pacheco Gahbler Carlos

机构信息

Hospital General "Dr. Manuel Gea González" Calzada de Tlalpan, #4800, Sección 16, Tlalpan, 14080, Ciudad de México, Mexico.

出版信息

Urol Case Rep. 2021 Oct 12;40:101896. doi: 10.1016/j.eucr.2021.101896. eCollection 2022 Jan.

DOI:10.1016/j.eucr.2021.101896
PMID:34745894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8551851/
Abstract

Primary neuroendocrine differentiation in prostate cancer occurs infrequently and represents a therapeutic challenge at present due to the poor prognosis involved. We present the case of a patient with de novo neuroendocrine prostate cancer who later developed metastases to adrenals bilaterally which were initially managed surgically.

摘要

前列腺癌中的原发性神经内分泌分化很少见，由于其预后较差，目前是一个治疗挑战。我们报告一例原发性神经内分泌前列腺癌患者，该患者后来双侧肾上腺发生转移，最初采用手术治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfae/8551851/43ead8894710/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfae/8551851/9c252cd3d9f3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfae/8551851/43ead8894710/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfae/8551851/9c252cd3d9f3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfae/8551851/43ead8894710/gr2.jpg

相似文献

1
Primary neuroendocrine prostate cancer with adrenal gland metastasis.原发性神经内分泌前列腺癌伴肾上腺转移。
Urol Case Rep. 2021 Oct 12;40:101896. doi: 10.1016/j.eucr.2021.101896. eCollection 2022 Jan.
2
Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.前列腺大细胞神经内分泌癌：一项系统评价与汇总分析
Urol Int. 2019;103(4):383-390. doi: 10.1159/000499883. Epub 2019 Apr 9.
3
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.原发性前列腺癌中的神经内分泌转分化：与临床病理特征进展和侵袭性结局相关的表型。
Med Oncol. 2021 Feb 14;38(3):26. doi: 10.1007/s12032-021-01473-2.
4
Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.垂体切除术在乳腺癌和前列腺癌播散性癌治疗中的应用。
South Med J. 1976 May;69(5):579-83. doi: 10.1097/00007611-197605000-00029.
5
Clinical and molecular features of treatment-related neuroendocrine prostate cancer.治疗相关神经内分泌前列腺癌的临床和分子特征
Int J Urol. 2018 Apr;25(4):345-351. doi: 10.1111/iju.13526. Epub 2018 Feb 3.
6
Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare Neuroendocrine Prostate Tumor.皮肌炎与红细胞增多症并存揭示罕见的神经内分泌前列腺肿瘤
Front Oncol. 2018 Nov 20;8:534. doi: 10.3389/fonc.2018.00534. eCollection 2018.
7
Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.前列腺癌伴神经内分泌分化的孤立性肺转移：一例报告及文献相关病例综述
World J Surg Oncol. 2015 May 7;13:173. doi: 10.1186/s12957-015-0598-2.
8
Low-serum prostate-specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer.低血清前列腺特异性抗原水平预示原发性神经内分泌前列腺癌患者预后不良。
Prostate. 2019 Sep;79(13):1563-1571. doi: 10.1002/pros.23878. Epub 2019 Aug 2.
9
Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation.前列腺癌伴神经内分泌分化中原发性和肝转移灶热点的程序性死亡配体 1（PD-L1）状态和肿瘤浸润淋巴细胞。
Clin Genitourin Cancer. 2019 Apr;17(2):145-153.e5. doi: 10.1016/j.clgc.2018.12.007. Epub 2018 Dec 21.
10
Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.前列腺癌中的神经内分泌分化。诊断、预后及治疗意义。
Cancer. 1992 Jul 1;70(1 Suppl):254-68. doi: 10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e.

引用本文的文献

1
Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes.病例报告：同时性前列腺癌和肾细胞癌，前列腺癌转移至肾上腺和肾门淋巴结。
Front Oncol. 2024 Oct 7;14:1412067. doi: 10.3389/fonc.2024.1412067. eCollection 2024.

本文引用的文献

1
Neuroendocrine and Aggressive-Variant Prostate Cancer.神经内分泌和侵袭性变异型前列腺癌
Cancers (Basel). 2020 Dec 16;12(12):3792. doi: 10.3390/cancers12123792.
2
Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes.神经内分泌前列腺癌：亚型、生物学和临床结局。
J Natl Compr Canc Netw. 2014 May;12(5):719-26. doi: 10.6004/jnccn.2014.0073.
3
A Case of Bilateral Adrenal and Pleural Metastases from Prostate Cancer.一例前列腺癌双侧肾上腺及胸膜转移病例
Case Rep Oncol. 2009 Nov 21;2(3):217-219. doi: 10.1159/000258964.